Skip to main content

Table 2 Therapeutic management

From: Cholelithiasis and cholecystitis in children and adolescents: Does this increasing diagnosis require a common guideline for pediatricians and pediatric surgeons?

 

Pediatric surgery group (n = 34)

Visceral surgery group (n = 53)

p value

Test

Time of symptoms [in months: median (range)]

4 (0–41)

1 (0–69)

0.075

U test

Time between diagnosis and surgery [median (range)]

15 days (0–12 months)

4 days (0–12 months)

0.128

U test

Complicated cases [n (%)]

  

0.390

Chi-square

 Yes

11 (32%)

22 (42%)

  

 No

23 (68%)

31 (58%)

  

Complications [n (%), multiple answers possible]

    

 Acute cholecystitis

8 (24%)

20 (38%)

0.116

Chi-square

 Cholangitis/choledocholithiasis

6 (18%)

5 (9%)

0.327

Fisher

 Pancreatitis

8 (24%)

3 (6%)

0.021*

Fisher

Approach [n (%)]

  

1.000

Fisher

 Laparoscopic

30 (88%)

46 (87%)

  

 Open

2 (6%)

4 (8%)

  

 Conversion

2 (6%)

3 (6%)

  

Duration of surgery [in minutes: median (range)]

136 (45–337)

86 (33–198)

 < 0.001*

U test

Diagnosis in histopathological evaluation [n (%)]

  

0.093

Fisher

 Acute inflammation

1 (3%)

10 (19%)

  

 Chronic inflammation

27 (79%)

35 (66%)

  

 Acute and chronic inflammation

6 (18%)

8 (15%)

  
  1. Therapeutic management of symptomatic cholecystolithiasis (complicated and uncomplicated cases) in the group of pediatric surgery patients in comparison with the group of visceral surgery patients
  2. Significant results are indicated by an asterisk